| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |